Back to today’s briefing

Story perspectives

New Urine Test Revolutionizes Prostate Cancer Detection

2/6/2025

36 6

Summary

Story summary

A groundbreaking at-home urine test, MyProstateScore 2.0 (MPS2), has been developed by researchers at the University of Michigan and Vanderbilt University to detect aggressive prostate cancer. By analyzing 18 genes with an impressive 92-94% sensitivity, MPS2 promises to minimize unnecessary biopsies and improve screening access, potentially transforming prostate cancer care, especially in underserved regions.

1 of 1

Story summary

A groundbreaking at-home urine test, MyProstateScore 2.0 (MPS2), has been developed by researchers at the University of Michigan and Vanderbilt University to detect aggressive prostate cancer. By analyzing 18 genes with an impressive 92-94% sensitivity, MPS2 promises to minimize unnecessary biopsies and improve screening access, potentially transforming prostate cancer care, especially in underserved regions.